2026 ICD-10-CM Diagnosis Code T48.6X1SPoisoning by antiasthmatics, accidental (unintentional), sequela

AHRQ’s CCSR groups this code into broader clinical categories.

• Albuterol

  a short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat asthma. albuterol is prepared as a racemic mixture of r(-) and s(+) stereoisomers. the stereospecific preparation of r(-) isomer of albuterol is referred to as levalbuterol.

• Albuterol, Ipratropium Drug Combination

  a combined pharmaceutical preparation of ipratropium bromide and albuterol sulfate that is used to treat the symptoms of asthma and chronic obstructive pulmonary disease.

• Aminophylline

  a drug combination that contains theophylline and ethylenediamine. it is more soluble in water than theophylline but has similar pharmacologic actions. it's most common use is in bronchial asthma, but it has been investigated for several other applications.

• Choline

  a basic constituent of lecithin that is found in many plants and animal organs. it is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism.

• Choline Deficiency

  a condition produced by a deficiency of choline in animals. choline is known as a lipotropic agent because it has been shown to promote the transport of excess fat from the liver under certain conditions in laboratory animals. combined deficiency of choline (included in the b vitamin complex) and all other methyl group donors causes liver cirrhosis in some animals. unlike compounds normally considered as vitamins, choline does not serve as a cofactor in enzymatic reactions. (from saunders dictionary & encyclopedia of laboratory medicine and technology, 1984)

• Choline Dehydrogenase

  an enzyme bound to the inner mitochondrial membrane that catalyzes the oxidation of choline to betaine.

• Choline Kinase

  an enzyme that is active in the first step of choline phosphoglyceride (lecithin) biosynthesis by catalyzing the phosphorylation of choline to phosphorylcholine in the presence of atp. ethanolamine and its methyl and ethyl derivatives can also act as acceptors. ec 2.7.1.32.

• Choline O-Acetyltransferase

  an enzyme that catalyzes the formation of acetylcholine from acetyl-coa and choline. ec 2.3.1.6.

• Choline-Phosphate Cytidylyltransferase

  an enzyme that catalyzes the transfer of cytidylate (cmp) to choline phosphate to form cdpcholine. it is the rate-limiting enzyme in the choline pathway for the biosynthesis of phosphatidylcholine. its activity is increased by glucocorticoids. ec 2.7.7.15.

• Cholinergic Agents

  any drug used for its actions on cholinergic systems. included here are agonists and antagonists, drugs that affect the life cycle of acetylcholine, and drugs that affect the survival of cholinergic neurons. the term cholinergic agents is sometimes still used in the narrower sense of muscarinic agonists, although most modern texts discourage that usage.

• Cholinergic Agonists

  drugs that bind to and activate cholinergic receptors.

• Cholinergic Antagonists

  drugs that bind to but do not activate cholinergic receptors, thereby blocking the actions of acetylcholine or cholinergic agonists.

• Cholinergic Fibers

  nerve fibers liberating acetylcholine at the synapse after an impulse.

• Cholinergic Neurons

  neurons whose primary neurotransmitter is acetylcholine.

• Cholinesterase Inhibitors

  drugs that inhibit cholinesterases. the neurotransmitter acetylcholine is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. when cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.

• Cholinesterase Reactivators

  drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. they are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates.

• Cholinesterases

  drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. they are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates.

• Cytidine Diphosphate Choline

  donor of choline in biosynthesis of choline-containing phosphoglycerides.

• Diacylglycerol Cholinephosphotransferase

  an enzyme that catalyzes the synthesis of phosphatidylcholines from cdpcholine and 1,2-diacylglycerols. ec 2.7.8.2.

• Glycerylphosphorylcholine

  a component of phosphatidylcholines or lecithins, in which the two hydroxy groups of glycerol are esterified with fatty acids. (from stedman, 26th ed)

• Leukemia Inhibitory Factor

  an interleukin-6 related cytokine that exhibits pleiotrophic effects on many physiological systems that involve cell proliferation, differentiation, and survival. leukemia inhibitory factor binds to and acts through the lif receptor.

• Muscarinic Agonists

  drugs that bind to and activate muscarinic cholinergic receptors (receptors, muscarinic). muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the gi tract, urinary bladder and the eye. they may also be used to reduce heart rate.

• Muscarinic Antagonists

  drugs that bind to but do not activate muscarinic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, gi system, and salivary glands, gi motility, urinary bladder tone, and the central nervous system.

• Neuroimmunomodulation

  the biochemical and electrophysiological interactions between the nervous system and immune system.

• Nicotinic Agonists

  drugs that bind to and activate nicotinic cholinergic receptors (receptors, nicotinic). nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission.

• Non-Neuronal Cholinergic System

  the system of acetylcholine-synthesizing enzymes, transporters, receptors and degrading enzymes that characterize non-neuronal cholinergic cells such as airway and skin epithelial cells.

• Phosphatidylcholines

  derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to a choline moiety.

• Phosphorylcholine

  calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.

• Receptors, Cholinergic

  cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology.

• Solute Carrier Family 44, Member 2 Protein

  a mitochondrion and plasma membrane protein that enables choline transmembrane transporter activity.

• Clenbuterol

  a substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. it is used as a bronchodilator in asthma.

• Fenoterol

  a synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.

• Hexoprenaline

  stimulant of adrenergic beta 2 receptors. it is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.

• Isoproterenol

  isopropyl analog of epinephrine; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. it is used mainly as bronchodilator and heart stimulant.

• Levalbuterol

  the r-isomer of albuterol.

• Nedocromil

  a pyranoquinolone derivative that inhibits activation of inflammatory cells which are associated with asthma, including eosinophils; neutrophils; macrophages; mast cells; monocytes; and platelets.

• Terbutaline

  a selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.

• Theophylline

  a methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. theophylline inhibits the 3',5'-cyclic nucleotide phosphodiesterase that degrades cyclic amp thus potentiates the actions of agents that act through adenylyl cyclases and cyclic amp.

• Tretoquinol

  an adrenergic beta-agonist used as a bronchodilator agent in asthma therapy.

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.